Literature DB >> 11080520

Potentiation of formalin-evoked adenosine release by an adenosine kinase inhibitor and an adenosine deaminase inhibitor in the rat hind paw: a microdialysis study.

X J Liu1, T D White, J Sawynok.   

Abstract

The present study examined the effects of local subcutaneous administration of formalin on adenosine release from the rat hind paw, and the effects of inhibitors of adenosine metabolism on such release. Microdialysis probes were inserted into the subcutaneous tissue of the plantar surface of rat hind paws. Samples were collected every 10 min at a perfusion rate of 2 microl/min and high performance liquid chromatography was used to measure adenosine levels. At lower concentrations of formalin (0.5-2.5%), a significant increase in adenosine levels was observed in the first 10 min after formalin injection, while at the highest concentration of formalin (5%), the increase in adenosine release was observed over 60 min. Co-administration of the adenosine kinase inhibitor 5'-amino-5'-deoxyadenosine (100 nmol) with formalin, significantly increased adenosine release evoked by 0.5-1.5% formalin, but did not produce a further enhancement of release evoked by 5% formalin. The adenosine deaminase inhibitor 2'-deoxycoformycin (100 nmol) significantly increased adenosine levels at 5% formalin but had no effect at lower concentrations of formalin. In confirmation of previous studies, subcutaneous injection of formalin (0.5-5%) produced a characteristic biphasic concentration-related expression of nociceptive behaviours and an increase in paw volume. This study directly demonstrates that formalin can evoke a concentration-dependent local release of adenosine from the rat hind paw. The ability of an adenosine kinase inhibitor and an adenosine deaminase inhibitor to modulate this release is dependent on substrate adenosine concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080520     DOI: 10.1016/s0014-2999(00)00742-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

2.  Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex.

Authors:  Xue Jun Liu; Jeffrey R Gingrich; Mariana Vargas-Caballero; Yi Na Dong; Ameet Sengar; Simon Beggs; Szu-Han Wang; Hoi Ki Ding; Paul W Frankland; Michael W Salter
Journal:  Nat Med       Date:  2008-11-16       Impact factor: 53.440

Review 3.  Adenosine kinase: A key regulator of purinergic physiology.

Authors:  Detlev Boison; Michael F Jarvis
Journal:  Biochem Pharmacol       Date:  2020-11-06       Impact factor: 5.858

Review 4.  The Role of Adenosine Signaling in Headache: A Review.

Authors:  Nathan T Fried; Melanie B Elliott; Michael L Oshinsky
Journal:  Brain Sci       Date:  2017-03-13

Review 5.  Therapeutic potential of adenosine kinase inhibition-Revisited.

Authors:  Michael F Jarvis
Journal:  Pharmacol Res Perspect       Date:  2019-07-22

Review 6.  Purinergic Signaling in Endometriosis-Associated Pain.

Authors:  Carla Trapero; Mireia Martín-Satué
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.